In line with the present study, we reported recently that LPS‐enriched cEVs from metabolic syndrome patients contribute to the low‐grade inflammation in these patients and trigger endothelial dysfunction by activation of TLR4. The gene discussed is TLR4; the disease is endothelial dysfunction.